Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Allergan Acquiesces To Activist Appaloosa With CEO-Chairman Role Split, But Not Yet

Mar 26 2019

• By Mandy Jackson

two horses running and playing in the snow in winter, American appaloosa, Kazakh breed, spotted horse - Image

Related Content

Activist Investors Seek Action At Allergan, But Are They Aligned?

Jun 07 2018

Medical Aesthetics: Sales Rise For Popular Products, But Unmet Needs Remain

Sep 12 2018

Allergan Thinks It’s Ready To Withstand Restasis Generics

Jan 29 2019

No Fire Sale: Allergan May Sell Women’s Health, Infectious Disease Units

May 30 2018

Teva to buy Allergan Generics; Mylan off the hook but Perrigo still wriggling

Jul 27 2015

Allergan paying $560m for Naurex; stays quiet on rumored generics sale to Teva

Jul 27 2015

Allergan Endures Another R&D Setback With Rapastinel Failing Three Pivotal Studies

Mar 07 2019

Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents

Oct 17 2017

Related Companies

Allergan plc

Teva Pharmaceutical Industries Ltd.

Naurex, Inc.

Bristol Myers Squibb Company

Kythera Biopharmaceuticals, Inc.

Additional Topics

Leadership Business Strategies Strategy Companies Commercial BioPharmaceutical

More from Leadership

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window